Sources | Names Used |
---|---|
CTRPv2 | selumetinib:GDC-0941 (4:1 mol/mol) |
PharmacoGx | selumetinib:GDC-0941 (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DLGAP5 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
mRNA | RP11-402G3.5 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
mRNA | SDPR | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
mRNA | ALDH1L2 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
mRNA | MYO6 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | STMN1 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
mRNA | GARS | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
mRNA | PPP2R5D | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
mRNA | YKT6 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | GPR160 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |